Trial intelligence / Profile preview

Longbitong granules in type III chronic prostatitis (IIa)

CTR20181420Phase 2Completed

Sponsor
Jichuan Pharmaceutical
Start
Aug 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Longbitong in chronic prostatitis (CP), sponsored by Jichuan Pharmaceutical. Started Aug 2018; status: completed.

02

Drugs

Longbitong
03

Conditions

chronic prostatitis (CP)

Beyond the preview

Go deeper on CTR20181420.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20181420.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call